Faeth Therapeutics, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $26.9M | $152.3M | $8.7M | $10.6M | $12.6M | $9.9M | $10.0M | $19.1M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $188.7M | $204.2M | $21.5M | $25.8M | $29.6M | $35.7M | $41.9M | $48.1M |
| Property, Plant & Equipment | $44.0K | $69.0K | $82.0K | $112.0K | $143.0K | $159.0K | $417.0K | $899.0K |
| Goodwill | $0 | $0 | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $189.3M | $205.4M | $22.9M | $27.6M | $31.8M | $38.3M | $45.4M | $53.3M |
| Liabilities | ||||||||
| Accounts Payable | $2.1M | $3.4M | $689.0K | $306.0K | $351.0K | $361.0K | $244.0K | — |
| Total Current Liabilities | $9.6M | $14.2M | $4.3M | $4.4M | $3.9M | $5.2M | $5.4M | $5.4M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $9.6M | $14.2M | $4.3M | $4.6M | $4.5M | $6.3M | $7.0M | $7.5M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-469.4M | $-453.4M | $-283.1M | $-278.4M | $-273.9M | $-268.9M | $-262.1M | $-254.3M |
| Total Stockholders' Equity | $173.0M | $-137.3M | $18.6M | $23.0M | $27.3M | $32.0M | $38.4M | $45.8M |